Synthesis and structure–activity relationship of potent, selective and orally active anthranilamide-based factor Xa inhibitors: Application of weakly basic sulfoximine group as novel S4 binding element
Keywords: ضد انعقاد، پادبند; Factor Xa; Anticoagulant; Anthranilamide; Sulfoximine